1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 234 results for "Multiple Myeloma (MM)".

$Thumbnail for Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma$

MM - 224

Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma

Anushareddy Muddasani

Poster Presenter: Anushareddy Muddasani

Thumbnail for Early Real-World Utilisation, Resource Use, and In-Hospital Outcomes of BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A National Inpatient Analysis, 2022-2023

MM - 225

Early Real-World Utilisation, Resource Use, and In-Hospital Outcomes of BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A National Inpatient Analysis, 2022-2023

Aniqa Baloch

Poster Presenter: Aniqa Baloch

SOHO 2026 Annual Meeting

Topics

Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma

Early Real-World Utilisation, Resource Use, and In-Hospital Outcomes of BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A National Inpatient Analysis, 2022-2023

Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma

Distinct Inpatient and Post-Discharge Risk States Defined by AKI and Acute Dialysis in Multiple Myeloma Hospitalizations

Reduced-Frequency Dosing of FDA-Approved Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Systematic Review of Maintaining Efficacy While Reducing Infection-Related Toxicity

Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors in Hematologic Malignancies: A Systematic Review of Recent Clinical Studies

Trends and Disparities in Mortality due to Multiple Myeloma and Malignant Plasma Cell Neoplasms Coexisting with Malignant Neoplasms: A 26-Year CDC Wonder Analysis From 1999 - 2024

Incidence of Parkinsonism and Non-ICANS Neurotoxicity with BCMA-Targeting Bispecific Antibodies vs CAR T-Cell Therapy in Multiple Myeloma: A Systematic Review and Meta-Analysis

Triplet vs Quadruplet Induction Regimens in Transplant-Eligible and Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials